(Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | (Q2)Mar 31, 2022 | (Q1)Dec 31, 2021 | (FY)Sep 30, 2021 | (Q4)Sep 30, 2021 | (Q3)Jun 30, 2021 | (Q2)Mar 31, 2021 | (Q1)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -47.45%-172.94K | -184.82%-53.95K | 67.44%-435.88K | 54.03%-117.29K | 96.57%-18.94K | -103.90%-1.34M | -74.38%-198.37K | -268.87%-333.61K | 52.29%-255.12K | -769.46%-551.64K |
Net income from continuing operations | 85.12%-61.3K | 14.16%-152.16K | -118.50%-2.05M | -34.81%-411.89K | 49.71%-177.27K | 11.08%-939.12K | 18.05%-229.45K | 47.87%-51.65K | -32.10%-305.53K | 20.93%-352.49K |
Operating gains losses | ---2.74K | --32.79K | --416 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization | ---- | ---- | --0 | ---- | ---- | --0 | ---- | ---- | --0 | --0 |
Asset impairment expenditure | ---- | ---- | 12,157.01%1.04M | ---- | ---- | -90.30%8.47K | ---- | ---- | ---- | ---- |
Unrealized gains and losses of investment securities | -202.64%-66.72K | ---17.77K | --84.49K | --65K | --0 | --0 | ---- | ---- | ---- | ---- |
Remuneration paid in stock | ---- | ---- | 80.57%365.3K | ---- | ---- | --202.3K | --0 | --0 | --0 | --202.3K |
Deferred tax | ---- | ---- | ---341.97K | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Other non cashItems | 89.95%-27K | 69.05%-4.22K | 91.76%-28.83K | -1,273.20%-268.53K | 90.29%-13.64K | -1,529.51%-349.68K | ---58.12K | ---131.47K | ---19.56K | -554.88%-140.53K |
Change In working capital | -111.43%-15.19K | -49.17%87.41K | 291.27%498.66K | 89.84%132.83K | 165.91%171.96K | -178.21%-260.71K | 2.58%80.74K | -1,852.53%-150.49K | 123.05%69.97K | -147.48%-260.93K |
-Change in receivables | -71.64%4.64K | -70.53%41.2K | 190.51%142.8K | -70.70%16.36K | 326.39%139.77K | -502.05%-157.77K | -714.65%-44.48K | -1,394.48%-107.38K | 3,715.61%55.83K | -262.68%-61.74K |
-Change in prepaid assets | 149.42%17.77K | 116.78%31.57K | -214.23%-60.67K | -187.63%-35.94K | 126.04%14.56K | -77.69%53.11K | 363.35%45.58K | -1.41%22.43K | 153.33%41.02K | -118.07%-55.92K |
-Change in payables and accrued expense | -104.90%-7.06K | 327.57%70.52K | 350.00%182.45K | 636.37%144.14K | 127.40%16.49K | -2,963.04%-72.98K | 102.24%79.64K | -397.99%-65.54K | 87.07%-26.87K | -140.39%-60.2K |
-Change in other current liabilities | -469.03%-30.53K | -5,010.11%-55.88K | 381.79%234.08K | --8.27K | 101.37%1.14K | -255.20%-83.07K | --0 | --0 | --0 | -256.56%-83.07K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -47.45%-172.94K | -184.82%-53.95K | 67.44%-435.88K | 54.03%-117.29K | 96.57%-18.94K | -103.90%-1.34M | -74.38%-198.37K | -268.87%-333.61K | 52.29%-255.12K | -769.46%-551.64K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 132.41%169.44K | -40.33%-390.55K | 98.52%-49.24K | 112.67%72.91K | 66.90%-278.3K | -429.55%-3.33M | -243.82%-1.1M | -1,171.53%-804.97K | -1,470.15%-575.33K | -143.55%-840.85K |
Net PPE purchase and sale | -88.89%8.1K | -65.95%-457.64K | 100.37%12.34K | 112.67%72.91K | 67.20%-275.78K | -425.16%-3.3M | -243.82%-1.1M | -1,134.82%-777.4K | -1,470.15%-575.33K | -143.55%-840.85K |
Net investment purchase and sale | --146.42K | --69.81K | ---- | --0 | --0 | ---- | ---- | ---- | ---- | ---- |
Net other investing changes | 248,883.33%14.93K | -7.78%-2.72K | -123.43%-61.58K | ---6 | ---2.52K | ---27.56K | --13 | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 132.41%169.44K | -40.33%-390.55K | 98.52%-49.24K | 112.67%72.91K | 66.90%-278.3K | -429.55%-3.33M | -243.82%-1.1M | -1,171.53%-804.97K | -1,470.15%-575.33K | -143.55%-840.85K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -84.50%729.63K | 238.44%4.71M | -107.29%-25K | 3,694.17%1.16M | -76.82%236.21K | 172,762.56%3.33M | ||||
Net common stock issuance | ---- | ---- | -83.14%750K | ---- | ---- | 304.39%4.45M | --0 | --1.26M | --0 | --3.19M |
Proceeds from stock option exercised by employees | ---- | ---- | --0 | ---- | ---- | 61.48%626.81K | --0 | --0 | --241.21K | --385.6K |
Net other financing activities | ---- | ---- | 94.47%-20.37K | ---- | ---- | -278.10%-368.22K | -400.10%-25K | -929.60%-99.66K | 93.81%-5K | -12,254.27%-238.56K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | ---- | ---- | -84.50%729.63K | ---- | ---- | 238.44%4.71M | -107.29%-25K | 3,694.17%1.16M | -76.82%236.21K | 172,762.56%3.33M |
Net cash flow | ||||||||||
Beginning cash position | 67.82%184.66K | 54.40%637.17K | 13.98%412.68K | -95.22%110.03K | 13.98%412.68K | 2.70%362.06K | 216.97%1.73M | 223.53%1.71M | 2,501.14%2.3M | 2.70%362.06K |
Current changes in cash | 141.62%18.47K | -49.54%-444.5K | 474.66%244.51K | 92.53%-44.38K | -115.31%-297.24K | -59.93%42.55K | -1,341.25%-1.33M | 50.36%23K | -232.70%-594.25K | 833.28%1.94M |
Effect of exchange rate changes | 47.90%-6.11K | -48.32%-8.01K | -348.07%-20.01K | -354.83%-11.72K | -1,111.61%-5.4K | 108.34%8.07K | 109.50%8.76K | -59.09%1.35K | 70.25%-2.58K | -36.35%534 |
End cash Position | 265.33%197.02K | 67.82%184.66K | 54.40%637.17K | -96.84%53.93K | -95.22%110.03K | 13.98%412.68K | 13.98%412.68K | 216.97%1.73M | 223.53%1.71M | 2,501.14%2.3M |
Free cash from | -271.47%-164.84K | -73.59%-511.6K | 90.60%-435.88K | 94.66%-44.38K | 78.84%-294.72K | -260.96%-4.64M | -199.51%-1.3M | -7,152.96%-1.11M | -45.33%-830.45K | -429.76%-1.39M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data